Hamdy Mohamed Abdelaziz Ahmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hamdy Mohamed Abdelaziz Ahmed has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Ayman Elbadawi
Division of Cardiology, Christus Good Shepherd Medical Center, Longview, USA
5 shared publications - Islam Y. Elgendy
Division of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky, Lexington, Kentucky
3 shared publications - Mohamed A. Omer
Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, MN, United States of America
3 shared publications Arka Chatterjee
Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama
2 shared publicationsGbolahan O. Ogunbayo
Department of Cardiovascular Medicine, University of Kentucky, Lexington
2 shared publications- Gbolahan O. Ogunbayo
Department of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky
2 shared publications
Latest Publications
- 2 July 2025
- Published by Elsevier in The Egyptian Rheumatologist
- Vol. 47 (4) , 187-191
Comparison of clinical characteristics of patients with Behҫet’s disease in two different geographical areas in the United States
- 2 July 2025
- Published by Elsevier in The Egyptian Rheumatologist
- Vol. 47 (4) , 187-191
Comparison of clinical characteristics of patients with Behҫet’s disease in two different geographical areas in the United States
- Open Access
- 13 February 2023
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 21 (1) , 1-14
IgG4 related pericardium and lung disease in pediatric patient complicated with fatal massive hemoptysis: a case report and review of literature
Background: IgG4-related disease (IgG4-RD) is a progressive and sometimes fatal disease that rarely affects pediatric age group. It may affect the orbits, lacrimal and salivary glands, pancreas, kidneys, peritoneum and other organs. Lung and pleura are not commonly reported in IgG4-RD. We here present a rare case of pediatric IgG4-RD with rare involvement of pericardium, pleura and lungs. Case presentation: A 13-year-old girl presented with intrathoracic IgG4-RD with pleuropericardial involvement. She showed initial improvement on prednisolone. Azathioprine and then mycophenolate failed to control relapses during steroid tapering. Her last relapse was treated by rituximab however, the patient developed acute fatal massive hemoptysis. Conclusions: Pediatric IgG4-RD is a rare entity with pericardio-pulmonary affection as the rare of the rare. Usual treatment of prednisolone and steroid sparing agents should be used, with rituximab used as a rescue therapy, but fatal complications may occur.
- 13 February 2023
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 21 (1) , 1-14
Open AccessIgG4 related pericardium and lung disease in pediatric patient complicated with fatal massive hemoptysis: a case report and review of literature
Background: IgG4-related disease (IgG4-RD) is a progressive and sometimes fatal disease that rarely affects pediatric age group. It may affect the orbits, lacrimal and salivary glands, pancreas, kidneys, peritoneum and other organs. Lung and pleura are not commonly reported in IgG4-RD. We here present a rare case of pediatric IgG4-RD with rare involvement of pericardium, pleura and lungs. Case presentation: A 13-year-old girl presented with intrathoracic IgG4-RD with pleuropericardial involvement. She showed initial improvement on prednisolone. Azathioprine and then mycophenolate failed to control relapses during steroid tapering. Her last relapse was treated by rituximab however, the patient developed acute fatal massive hemoptysis. Conclusions: Pediatric IgG4-RD is a rare entity with pericardio-pulmonary affection as the rare of the rare. Usual treatment of prednisolone and steroid sparing agents should be used, with rituximab used as a rescue therapy, but fatal complications may occur.
- 1 December 2020
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 21 (12) , 1560-1566
Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair and Surgical Mitral Valve Intervention
- 1 December 2020
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 21 (12) , 1560-1566
Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair and Surgical Mitral Valve Intervention
- 1 October 2020
- Published by Elsevier in The American Journal of Medicine
- Vol. 133 (10) , 1168-1179.e4
Outcomes of Acute Myocardial Infarction in Patients with Rheumatoid Arthritis
- 1 October 2020
- Published by Elsevier in The American Journal of Medicine
- Vol. 133 (10) , 1168-1179.e4
Outcomes of Acute Myocardial Infarction in Patients with Rheumatoid Arthritis
- Open Access
- 1 March 2020
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (3) , 414-419
A Case of Heart Failure in a Patient With Systemic Lupus Erythematosus
- 1 March 2020
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (3) , 414-419
Open AccessA Case of Heart Failure in a Patient With Systemic Lupus Erythematosus
- 31 December 2019
- Published by Springer Nature
- p. 181-201
Antiphospholipid Syndrome
- Open Access
- 20 December 2019
- Published by Wiley in Clinical Cardiology
- Vol. 43 (3) , 260-266
Absence of left bundle branch block and blood urea nitrogen predict improvement in left ventricular ejection fraction in patients with cardiomyopathy and wearable cardioverter defibrillators
Objective: To identify predictors of left ventricular ejection fraction (LVEF) improvement in patients with newly detected cardiomyopathy using wearable cardioverter defibrillators (WCDs).Background: WCDs are useful in preventing sudden cardiac death in patients with reduced LVEF P = .006), having lower blood urea nitrogen (BUN) (19 vs 24 mg/dL, P = .002), fewer left bundle branch block (LBBB 9.5% vs 25.8%, P = .004), shorter QRS duration (98 vs 112 ms, P < .001), and higher use of angiotensin converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) (92.9% vs 74.4%, P = .001) compared to those without LVEF improvement. Absence of LBBB (odds ratio [OR] 0.28, 95% confidence interval [CI] 0.11‐0.70), lower BUN (OR 0.13, 95% CI 0.02‐0.76), and ACEI/ARB use (OR 3.53, 95% CI 1.28‐9.69) were identified as independent predictors. Ventricular tachycardia/ventricular fibrillation was observed in three patients, all of whom received successful WCD shocks.Conclusion: Absence of LBBB, lower BUN, and ACEI/ARB use predicts LVEF improvement. WCDs help treat arrhythmic events.
- 20 December 2019
- Published by Wiley in Clinical Cardiology
- Vol. 43 (3) , 260-266
Open AccessAbsence of left bundle branch block and blood urea nitrogen predict improvement in left ventricular ejection fraction in patients with cardiomyopathy and wearable cardioverter defibrillators
Objective: To identify predictors of left ventricular ejection fraction (LVEF) improvement in patients with newly detected cardiomyopathy using wearable cardioverter defibrillators (WCDs).Background: WCDs are useful in preventing sudden cardiac death in patients with reduced LVEF P = .006), having lower blood urea nitrogen (BUN) (19 vs 24 mg/dL, P = .002), fewer left bundle branch block (LBBB 9.5% vs 25.8%, P = .004), shorter QRS duration (98 vs 112 ms, P < .001), and higher use of angiotensin converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) (92.9% vs 74.4%, P = .001) compared to those without LVEF improvement. Absence of LBBB (odds ratio [OR] 0.28, 95% confidence interval [CI] 0.11‐0.70), lower BUN (OR 0.13, 95% CI 0.02‐0.76), and ACEI/ARB use (OR 3.53, 95% CI 1.28‐9.69) were identified as independent predictors. Ventricular tachycardia/ventricular fibrillation was observed in three patients, all of whom received successful WCD shocks.Conclusion: Absence of LBBB, lower BUN, and ACEI/ARB use predicts LVEF improvement. WCDs help treat arrhythmic events.
- 1 October 2019
- Published by Elsevier in The American Journal of Cardiology
- Vol. 124 (7) , 1099-1105
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Rheumatoid Arthritis (from the Nationwide Inpatient Database)
- 1 October 2019
- Published by Elsevier in The American Journal of Cardiology
- Vol. 124 (7) , 1099-1105
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Rheumatoid Arthritis (from the Nationwide Inpatient Database)
- 28 May 2019
- Published by Springer Nature in Rheumatology International
- Vol. 39 (7) , 1279-1284
Urethral involvement in granulomatosis with polyangiitis: a case-based review
Granulomatosis with polyangiitis (GPA) commonly presents with glomerulonephritis and inflammation of upper and lower respiratory tracts. It can also involve other organs including those of the urinary tract. The involvement of the urethra is very rarely reported. We present a case of GPA in a patient who had recurrent urinary tract infections and an acute bladder outlet obstruction due to a urethral thickening by GPA. In this report, we discuss urethral involvement with GPA. The incidence of such involvement, as with other urinary tract organs, might be underestimated. It can affect both sexes, with male predominance, and can occur at any age. It responds to standard GPA medical treatment but may require surgical intervention. Rheumatologists should be aware of this limited form of GPA as early recognition and treatment can decrease the risk of complications.
- 28 May 2019
- Published by Springer Nature in Rheumatology International
- Vol. 39 (7) , 1279-1284
Urethral involvement in granulomatosis with polyangiitis: a case-based review
Granulomatosis with polyangiitis (GPA) commonly presents with glomerulonephritis and inflammation of upper and lower respiratory tracts. It can also involve other organs including those of the urinary tract. The involvement of the urethra is very rarely reported. We present a case of GPA in a patient who had recurrent urinary tract infections and an acute bladder outlet obstruction due to a urethral thickening by GPA. In this report, we discuss urethral involvement with GPA. The incidence of such involvement, as with other urinary tract organs, might be underestimated. It can affect both sexes, with male predominance, and can occur at any age. It responds to standard GPA medical treatment but may require surgical intervention. Rheumatologists should be aware of this limited form of GPA as early recognition and treatment can decrease the risk of complications.